m2163

General Information


DRACP ID  DRACP02325

Peptide Name   m2163

Sequence  KRKCPKTPFDNTPGAWFAHLILGC

Sequence Length  24

UniProt ID  Q036G0  K0N7G0  K6RXD6 

PubChem CID  Not available

Origin  Lactobacillus casei; Lactobacillus paracasei

Type  Native peptide

Classification

  

Active ACP Induce apoptosis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
SW480 Colon adenocarcinoma Carcinoma IC50=40 µg/ml MTT assay 24 h 1
BFTC-905 Bladder carcinoma Carcinoma ~40% Cell death=40 µg/ml MTT assay 24 h 1
CaCo-2 Colon adenocarcinoma Carcinoma ~40% Cell death=40 µg/ml MTT assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  H184B5F5/M10: ~20% Cell death=40 µg/ml; CHO-K1: ~40% Cell death=40 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02325

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys4<--->Cys24

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C124H190N34O30S2

Absent amino acids  EMQSVY

Common amino acids  KP

Mass  311164

Pl  9.67

Basic residues  5

Acidic residues  1

Hydrophobic residues  8

Net charge  4

Boman Index  -2562

Hydrophobicity  -33.33

Aliphatic Index  57.08

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5625

Absorbance 280nm  244.57

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25557887

Title  Antimicrobial peptide m2163 or m2386 identified from Lactobacillus casei ATCC 334 can trigger apoptosis in the human colorectal cancer cell line SW480

Doi 10.1007/s13277-014-3018-2

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_4143

DRACP is developed by Dr.Zheng's team.